GlassScriptPhysician profile
Kaveh Sadeghi
NPI 1073832044
$8,061.32
in general payments reported to CMS, 2019-2025
40 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $498 · 2021: $1,130 · 2022: $1,046 · 2023: $1,559 · 2024: $1,733 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,098.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,534.46 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,113.45 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $757.19 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $722.23 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.36 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $379.68 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $337.09 | 2021-2025 | |
| Ucb, INC. | $271.79 | 2022-2023 | Cimzia |
| Lundbeck LLC | $236.73 | 2022-2025 | Rexulti |
| Exact Sciences Corporation | $209.03 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $185.29 | 2019-2024 | |
| Amgen INC. | $181.35 | 2023-2025 | Otezla, Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $177.03 | 2021-2025 | Rexulti |
| Astellas Pharma US INC | $171.09 | 2019-2025 | Veozah |
| Gilead Sciences, INC. | $163.29 | 2024-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $140.09 | 2021-2025 | Freestyle Libre 3 |
| Arbor Pharmaceuticals, INC. | $121.18 | 2019-2022 | |
| Dexcom, INC. | $101.71 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $100.46 | 2021-2024 | |
| Abbvie INC. | $88.13 | 2023-2025 | Linzess, Vraylar |
| Merck Sharp & Dohme LLC | $61.43 | 2019-2022 | |
| Horizon Therapeutics Plc | $55.87 | 2019-2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $52.24 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $51.67 | 2022 | |
| Globus Medical, INC. | $41.80 | 2025 | Senza |
| Amarin Pharma, INC. | $39.23 | 2021 | |
| Phadia US INC. | $36.43 | 2024-2025 | Immunocap |
| Azurity Pharmaceuticals, INC. | $33.62 | 2023-2024 | Edarbi, Edarbi |
| Actelion Pharmaceuticals US, INC. | $31.27 | 2023 | Opsumit |
| Hologic Sales and Service, LLC | $28.83 | 2025 | Aptima |
| Eisai INC. | $28.25 | 2021 | |
| Corium, LLC | $26.21 | 2023 | Azstarys |
| Alnylam Pharmaceuticals INC. | $22.29 | 2025 | Givlaari |
| Viatris Specialty LLC | $20.28 | 2025 | Yupelri |
| Phathom Pharmaceuticals, INC. | $19.64 | 2024 | Voquezna |
| Corcept Therapeutics | $19.18 | 2021 | |
| Axsome Therapeutics, INC. | $18.16 | 2024 | Auvelity |
| Viiv Healthcare Company | $17.64 | 2024 | Apretude |
| Global Blood Therapeutics, INC. | $17.05 | 2022 | |
| Currax Pharmaceuticals LLC | $13.60 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaveh Sadeghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.